Search Results 901-910 of 17031 for ozempic

1. Surgery - Doctors - Mayo Clinic

   Mayo Clinic Surgery offers deep expertise and a wide range of surgical care to tens of thousands of people each year.

2. Evaluation of Safety, Tolerability, and Effectiveness of INZ-701 in Adults With ENPP1 Deficiency - Mayo Clinic

   The purpose of this study is to assess safety and tolerability of INZ-701, a recombinant Ectonucleotide Pyrophosphatase/Phosphodiesterase (ENPP1) enzyme, for ...

3. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

   This study will evaluate the safety, efficacy, and pharmacokinetics of atezolizumab in combination with bevacizumab, bevacizumab + oxaliplatin, leucovorin and 5 ...

4. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

   A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

5. Measuring Cell Free DNA During The Course Of Treatment For Esophageal Cancer As A Marker Of Response And Recurrence - Mayo Clinic

   About this study. To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can ...

6. A Study to Validate Current Machine Learning Models for Hemodynamic Instability in Humans - Mayo Clinic

   The primary purpose of this study is to provide a subset of data using protocols of tolerance to lower-body negative pressure for validation of a commercially ...

7. Study to Evaluate Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique - Mayo Clinic

   About this study. The purpose of this study is to investigate if Hybrid Argon Plasma Coagulation (HAPC) is non-inferior to Radiofrequency Ablation (RFA) in ...

8. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

9. Catheter Ablation Vs Anti-arrhythmic Drug Therapy For Atrial Fibrillation Trial - Mayo Clinic

   About this study. Is the treatment strategy of percutaneous left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) superior ...

10. A Study Of New Laboratory Assays To Develop Better Therapies For Treating Patients With Graves’ Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...